Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Post-Marketing Data Will Drive Coverage Decisions Under Medicare, CMS Suggests

This article was originally published in The Pink Sheet Daily

Executive Summary

"The nexus between payment and reimbursement and approval is going to be awfully tight now that we're in a prescription drug benefit," CMS Senior Policy Advisor Trysla says.
Advertisement

Related Content

McClellan To Head Medicare Rx Law Implementation: Will Greater FDA/CMS Cooperation Ensue?
McClellan To Head Medicare Rx Law Implementation: Will Greater FDA/CMS Cooperation Ensue?
AHRQ Comparative Effectiveness Research Supported By GOP; Too Late For Budget Request

Topics

Advertisement
UsernamePublicRestriction

Register

PS059133

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel